Conference Proceedings

Outcomes of the First 44 Patients at 48 Weeks in the HBV-STOP Study, a Prospective Study of Nucleot(s)Ide Analogue Discontinuation in Non-Cirrhotic Hbeag-Negative Chronic Hepatitis B Patients Who Have Achieved Long Term Virological Suppression

Samuel Hall, Gareth Burns, Miriam T Levy, John S Lubel, Amanda Nicoll, Gail Matthews, Paul V Desmond, William Sievert, Scott Bowden, Stephen Locarnini, Kumar Visvanathan, Alexander Thompson

HEPATOLOGY | WILEY | Published : 2018


Funding Acknowledgements

Amanda Nicoll - MSD: Grant/Research SupportGail Matthews - Gilead: Grant/Research Support; Abbvie: Grant/Research Support; Gilead: Speaking and TeachingStephen Locarnini - SpringBank Pharmaceuticals, Inc.: Consulting; SpringBank Pharmaceuticals, Inc.: Grant/Research Support; SpringBank Pharmaceuticals, Inc.: Independent ContractorKumar Visvanathan - Qiagen: Advisory Committee or Review Panel; Gilead: Grant/Research Support; Abbvie: Grant/Research Support